Financing

Net change in commercial paper

AbbVie Net change in commercial paper decreased by 1150.0% to -$550.00M in Q3 2025 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ3 2025

How to read this metric

Increased reliance on commercial paper may signal tight cash flow or seasonal working capital needs.

Detailed definition

This represents the net change in short-term unsecured debt obligations issued by the company to meet immediate working...

Peer comparison

Standard for large-cap companies with high credit ratings and active treasury operations.

Metric ID: cf_commercial_paper_net

Historical Data

14 periods
 Q2 '21Q3 '21Q4 '21Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.59B-$44.00M-$550.00M
QoQ Change-102.8%<-999%
Range-$550.00M$1.59B
Current Streak2+ quarters decline

Frequently Asked Questions

What is AbbVie's net change in commercial paper?
AbbVie (ABBV) reported net change in commercial paper of -$550.00M in Q3 2025.
What does net change in commercial paper mean?
The net increase or decrease in short-term debt issued to fund operations.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.